Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial
Download the PDF here.
This post appeared first on investingnews.com
Cyprium Metals Limited (ASX: CYM, OTC: CYPMF) (Cyprium or the Company) is pleased to announce the successful completion of…
The US Federal Reserve announced an interest rate cut of 25 basis points on Wednesday (December 18), reducing its…
The United Nations has designated 2025 as the year of quantum science and technology, highlighting the profound impact that…
(TheNewswire) TheNewswire – Troy Minerals Inc. (‘ Troy ‘ or the ‘ Company ‘ ) (CSE: TROY; OTCQB: TROYF;…
The uranium market entered 2024 on strong footing after a year of significant price movement, as well as renewed…
Investor and author Gianni Kovacevic shared his thoughts on copper market dynamics, saying that while the long-term trend is…
Investor Insight Jindalee Lithium’s flagship McDermitt Lithium Project (McDermitt) offers investors exposure to a generational, high-margin critical minerals asset.…